Entity Public Float of Grace Therapeutics, Inc. from 30 Sep 2019 to 30 Sep 2024

Taxonomy & unit: dei: USD
Description: The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary: Grace Therapeutics, Inc. quarterly Entity Public Float in USD history and change rate from 30 Sep 2019 to 30 Sep 2024.
Grace Therapeutics, Inc. Entity Public Float for the quarter ending 30 Sep 2024 was $24,040,390, a 36% increase year-over-year.
Source SEC data: View on sec.gov

Entity Public Float, Quarterly (USD)

Entity Public Float, YoY Quarterly Change (%)

Grace Therapeutics, Inc. Quarterly Entity Public Float (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2024	$24,040,390	+$6,422,955	+36%	30 Sep 2024	10-K	23 Jun 2025	2025	FY
Q3 2023	$17,617,435			30 Sep 2023	10-K	21 Jun 2024	2024	FY
Q1 2023	$26,031,587			31 Mar 2023	10-K	23 Jun 2023	2023	FY
Q3 2021	$25,942,990	+$6,569,161	+34%	30 Sep 2021	10-K/A	29 Jul 2022	2022	FY
Q3 2020	$19,373,829	-$141,631,670	-88%	30 Sep 2020	10-K	22 Jun 2021	2021	FY
Q3 2019	$161,005,499			30 Sep 2019	10-K	29 Jun 2020	2020	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.